MaxCyte Inc (MXCT : NASDAQ)
Common Stock
$1.25
USD
+0.29 (29.63%)
Last updated: 2026-10-14
Follow MXCT
MXCT
MaxCyte Inc
WealthAwesomePerformance
1 Day
+29.63%
1 Week
+20.19%
1 Month
+6.38%
YTD
+10.62%
Key Statistics
Market Cap
$99.52M
52W High
$1.80
52W Low
$0.64
P/E Ratio
-
50 Day MA
$1.20
200 Day MA
$1.07
Beta
1.49
Dividend Yield
-
Advertisement
Technical Indicators
Price vs 50-Day SMA
Price vs 200-Day SMA
Recent Price History
| Date | Open | High | Low | Close | Adj Close | Volume |
|---|---|---|---|---|---|---|
| 10/14/2026 | $1.23 | $1.33 | $1.20 | $1.25 | $1.25 | 12,565,524 |
| 10/13/2026 | $0.98 | $1.01 | $0.94 | $0.96 | $0.96 | 327,904 |
| 10/12/2026 | $1.01 | $1.01 | $0.97 | $0.99 | $0.99 | 150,022 |
| 10/9/2026 | $1.02 | $1.03 | $0.99 | $1.01 | $1.01 | 240,000 |
| 10/8/2026 | $1.04 | $1.04 | $0.96 | $1.02 | $1.02 | 476,655 |
| 10/7/2026 | $1.07 | $1.08 | $1.04 | $1.04 | $1.04 | 311,840 |
| 10/6/2026 | $1.09 | $1.10 | $1.05 | $1.09 | $1.09 | 333,083 |
| 10/5/2026 | $1.08 | $1.10 | $1.06 | $1.08 | $1.08 | 194,767 |
| 10/2/2026 | $1.11 | $1.11 | $1.07 | $1.07 | $1.07 | 228,100 |
| 10/1/2026 | $1.12 | $1.16 | $1.08 | $1.09 | $1.09 | 397,067 |
Analyst Price Targets
Based on 6 analysts covering MXCT · as of Oct 5, 2026
Wall Street analysts forecast MXCT stock price to rise 228.6% over the next 12 months.
Consensus
Strong Buy4.67 / 5.00
Avg. Target
US$4.11
+228.6% Upside
Current Price
US$1.25
Last close
Analyst Breakdown (6 analysts)
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on MXCT's historical volatility
30-Day Vol
85.0%
Annualized
90-Day Vol
72.6%
Annualized
Trend (90d)
+6.8%
Annualized drift
90d Mean
US$1.28
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | US$1.26 | US$0.94 – US$1.69 |
| 60 trading days | US$1.27 | US$0.84 – US$1.92 |
| 90 trading days | US$1.28 | US$0.77 – US$2.13 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
About MaxCyte Inc
MaxCyte, Inc., a life sciences company, discovers, develops, and commercializes cell therapeutics in the United States and internationally. The company's products consists of ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expression of therapeutic targets for cell-based assays; ExPERT GTx, a flow electroporation for large scale transfection in therapeutic applications; and ExPERT VLx for very large volume cell-engineering. It also provides disposable processing assemblies (PAs) to process and electroporate cells; and accessories supporting PAs, such as electroporation buffer solution and software protocols. The company licenses and sells its instruments and technology; and sells its consumables to developers of cell therapies, as well as to pharmaceutical and biotechnology companies for use in drug discovery and development, and bio-manufacturing. The company has strategic partnership with VectorBuilder focused on co-developing a new gene delivery solution. MaxCyte, Inc. was incorporated in 1998 and is headquartered in Rockville, Maryland.
Financials
- Revenue (TTM)
- $31.05M
- EBITDA
- $-30.29M
- Profit Margin
- -114.77%
- ROE (TTM)
- -20.39%
- EPS (Diluted)
- -0.34
- Book Value
- 1.50
Classification
- Sector
- Health Care
- Industry
- Health Care Equipment & Supplies
- Group
- Health Care Equipment & Services
7 stocks to buy and hold forever
Blue-chip dividend stocks for long-term wealth building.
Get the FREE ReportExplore More
Advertisement
Common Questions About MXCT.US
Market movers
Recent NASDAQ movers
Top 1-day gainers — updated from our Canadian movers feed.
| Ticker | Name | Price | 1D |
|---|---|---|---|
| NVNI | Nvni Group Limited Ordinary Shares | $0.53 | +382.56% |
| HVII | Hennessy Capital Investment Corp. VII Ordinary Shares | $4.46 | +150.56% |
| SOBR | Sobr Safe Inc | $0.08 | +94.88% |
| GLND | Greenland Energy Company Common Stock | $3.90 | +76.47% |
| TGL | Treasure Global Inc. | $0.45 | +61.87% |
| NIVF | NewGenIvf Group Limited Class A Ordinary Shares | $0.29 | +50.20% |
| CRANR | Crane Harbor Acquisition Corp. II Rights | $0.16 | +45.47% |
| HCICR | Hennessy Capital Investment Corp. VIII Share Rights | $0.12 | +41.53% |